China will build a modern pharmaceutical industry system, this sentence is correct.
November 17, 2023, 2023 China's pharmaceutical industry development conference opened in Beijing. The reporter learned at the conference, since 2021, China's pharmaceutical industry industry-wide R & D investment average annual growth of 23%, innovative drugs, high-end medical devices and other areas of innovation continues to emerge, the pharmaceutical reserve system continues to improve. The next step, China will accelerate the construction of a modern pharmaceutical industry system, comprehensively improve the level of supply security.
The relevant person in charge of the Ministry of Industry and Information Technology introduced that the next step will be to accelerate the research and development and industrialization of pharmaceutical products, promote the optimization and upgrading of the whole industrial chain, enhance the ability to guarantee key products, and continue to promote a high level of openness and cooperation, to accelerate the construction of a modern pharmaceutical industrial system, and to comprehensively enhance the level of supply security.
China will build a modern pharmaceutical industrial system of measures
Building a modern pharmaceutical industrial system requires accelerating product research and development and industrialization. Around the chemical drugs, traditional Chinese medicine, biological drugs, medical devices, in-depth implementation of pharmaceutical innovative products industrialization project and pharmaceutical industrialization technology research project, accelerate the pace of industrialization and marketization of new products, and promote innovative products listed as early as possible.
In addition, it will also promote the optimization and upgrading of the whole industrial chain, consolidate and enhance the advantages of API manufacturing, develop and grow antibody drugs, new vaccines and other biopharmaceutical industries, and promote the industry to accelerate the extension of the high-end value chain. Enhance the ability to protect key products, strengthen the production capacity of key products, improve the pharmaceutical reserve system; promote high-level open cooperation, encourage multinational corporations to set up R & D centers and innovative drug production bases in China, and support the introduction of foreign advanced technology and products by domestic enterprises through co-development, technology licensing and other means.